The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease: A population-based retrospective cohort study
Conclusions: Our results demonstrated a decreased risk of DM in UGID patients who used PPIs; the risk appeared to be significantly dose-dependent.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Gout | Health | Health Insurance | Hypertension | Insurance | Internal Medicine | Obesity | Pancreatitis | Proton Pump Inhibitors PPIs | Stroke | Study | Zyprexa